European Psychiatry - Volume 41 - April 2017

844 / 916

S840 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S772–S846
4 UFABC, Center of Mathematics Computation ad Cognition, Santo
André, Brazil
5 Centro Universitário do Estado do Pará, Faculty of Medicine, Belém,
Brazil
∗ Corresponding author.
Introduction Hypothyroidism psychocognitive key features may
include melancholia, memory impairment, depression and demen-
tia which could be misdiagnosed as a psychiatric disorder.
Objective To study the incidence of hypothyroidism in psychi-
atric patients.
Methods This retrospective study included 232 psychiatric
patients with mean age of 43.39 ± 10 years old weight mean of
79.81 ±19.07 kg, BIM of 29.55 ±6.83, enrolled in a public mental
health service.
Results Twenty point twenty-one percent (39) patients pre-
sented hypothyroidism with thyroid-stimulating hormone (TSH)
levels above 5 mIU/L and Free T4 levels below 0.7 ng/dl.
Comparing the incidence of hypothyroidism in Brazilian population
estimated rate of until 10% ith this psychiatric patients popu-
lation we observed a significant difference with p value of 2.28 E-6.
Neuroleptics 92%(36), biperiden 62%(24) and benzodiazepines 38%
(15) were the most frequent prescribed drugs for these hypothy-
roidism patients.
Conclusion Significant difference in the incidence of hypothy-
roidism between general Brazilian population and the studied
psychiatric patients was observed
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
References
[1] Sgarbi JA, Teixeira PF, Maciel LM, Mazeto GM, Vaisman M,
Montenegro Junior RM, et al. Consenso brasileiro para a abor-
dagem clínica e tratamento do hipotireoidismo subclínico
em adultos: recomendac¸ ões do Departamento de Tireoide da
Sociedade Brasileira de Endocrinologia e Metabologia. Arq
Bras Endocrinol Metab 2016;57(3):166–83,
[Internet, citado 2016
16].
[2] Praharaj SK. How prevalent are depression anxiety
symptoms inhypothyroidism? Indian. Endocrinol Metab
2016;20(6):882–3 [PubMedPMID: 27867899].
[3] Kelly T. A hypothesis on the mechanism of action of high-
dose thyroid inrefractory mood disorders. Med Hypotheses
2016;97:16–21,
[PubMed PMID: 27876122.].
EV1328
Issues surrounding severe psychiatric
post-patients’ community living in
Japan; how can we best prepare them?
M. Tanoue ∗, J. Niimura , M. Hirabayashi , Y. Nonaka
1 Tokyo Medical and Dental University, Graduate School of Heath
Care Science, Bunkyo-Ku Tokyo, Japan
2 Tokyo Metropolitan Institute of Medical Science, Mental Health and
Nursing Research Team, Bunkyo-Ku Tokyo, Japan
3 The University of Tokyo, Global Health Policy- Graduate School of
Medicine, Bunkyo-Ku Tokyo, Japan
∗ Corresponding author.
Introduction The average length of stay in Japan at psychiatric
hospital is 292 days. In recent years, measures to shorten the hos-
pitalisation period are being promoted.
Objective To understand patients who were discharged from
emergency ward/acute psychiatric care units the needs post-
discharge, in order to improve the quality of psychiatric nursing
care at the psychiatric out patient care.
Methods Sixty-two patientswho have been hospitalised in emer-
gency ward/acute psychiatric care units, with a diagnosis of
schizophrenia and mood disorders, and currently visiting the out-
patient department of psychiatric care were selected as the subject.
Semi-structured interviews were conducted.
Results The issues that patients faced post-discharged were;
– daily life issues: how to support themselves, how to cook, what
to eat, and how to sleep;
– relationship with families and supporters;
– concerns of their conditions such as anxiety, restlessness, disaf-
fection, loneliness, isolated feeling, drowsiness. Patients consulted
their family members, their doctors, or professionals other than
doctors.
Conclusion The needs for the support for patients who recently
discharged from an acute psychiatric ward were high, with the
instability of the patient as well as the possibility of worsen-
ing their symptoms. There was a high demand for professionals
other than a doctor as a consultant, given the limited consulting
resources the patients have. The patients’ concerns post-discharge
varied widely, focusing mainly on their daily lives. Support sys-
tem, including monitoring, is necessary during early stages of
discharge.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1329
Corticosteroid-induced psychosis:
Case report and review of the
literature
M. Tenorio Guadalupe ∗, I. Alberdi Páramo
H.C.U. San Carlos, Psychiatry, Madrid, Spain
∗ Corresponding author.
Introduction Steroid psychosis still presentsmany unsettled clin-
ical aspects. Despite several reviews and case reports are available,
modes of onset and recovery need a more accurate description.
We will focus on a 53-year-old woman who was hospitalized
against her will because of her agitated psychotic state. Her symp-
toms were indicative of an acute psychotic disorder resulting from
the use of corticosteroids. We considered it important to report
this case because corticosteroids have been widely prescribed
since about 1950 to treat a broad spectrum of somatic illnesses
and to emphasize the relevance of the dose of steroids in this
case.
Objectives We describe a case of substance-induced psychotic
disorder resulting from corticosteroids administration and we
review the scientific literature about this topic.
Aims To obtain more information about the incidence of steroid-
induced psychotic symptoms, the relation between the type of
steroids, its dose and the clinical presentation, the most impor-
tant risk factors and how to prevent psychotic episodes during
steroids-treatment.
Methods After discussing the case, we studied the literature sys-
tematically using official medical browsers.
Results Very little reliable evidence has been available relating to
steroid-induced psychosis.
Conclusions There is much to learn about adverse psychiatric
reactions to corticosteroid treatment. It should be improved aware-
ness of the limited available knowledge and to stimulate research
aimed at improved methods of prevention, recognition and treat-
ment.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.